Cargando…
Potential Targeting of Renal Fibrosis in Diabetic Kidney Disease Using MicroRNAs
Diabetic kidney disease (DKD) is a major health problem and one of the leading causes of end-stage renal disease worldwide. Despite recent advances, there exists an urgent need for the development of new treatments for DKD. DKD is characterized by the excessive synthesis and deposition of extracellu...
Autores principales: | Sakuma, Hiroko, Hagiwara, Shinji, Kantharidis, Phillip, Gohda, Tomohito, Suzuki, Yusuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751689/ https://www.ncbi.nlm.nih.gov/pubmed/33364960 http://dx.doi.org/10.3389/fphar.2020.587689 |
Ejemplares similares
-
MicroRNA in Diabetic Nephropathy: Renin Angiotensin, AGE/RAGE, and Oxidative Stress Pathway
por: Hagiwara, Shinji, et al.
Publicado: (2013) -
MicroRNAs as potential targets for progressive pulmonary fibrosis
por: Rajasekaran, Subbiah, et al.
Publicado: (2015) -
Fractional excretion of tumor necrosis factor receptor 1 and 2 in patients with type 2 diabetes and normal renal function
por: Gohda, Tomohito, et al.
Publicado: (2020) -
MicroRNAs in renal fibrosis
por: Chung, Arthur C.-K., et al.
Publicado: (2015) -
Diagnostic and Therapeutic Potential of microRNAs in Acute Kidney Injury
por: Brandenburger, Timo, et al.
Publicado: (2020)